Lee et al., 2007 - Google Patents
Genetic effect of CCR3 and IL5RA gene polymorphisms on eosinophilia in asthmatic patientsLee et al., 2007
View PDF- Document ID
- 7500150731169700246
- Author
- Lee J
- Chang H
- Kim J
- Park S
- Lee Y
- Uh S
- Rhim T
- Chung I
- Kim Y
- Park B
- Park C
- Shin H
- Publication year
- Publication venue
- Journal of allergy and clinical immunology
External Links
Snippet
BACKGROUND: Eosinophilic infiltration and peripheral blood eosinophilia in asthma require the cooperation of eosinophil-specific cytokines and chemokines and their receptors. OBJECTIVE: We investigated the association of polymorphisms in CCR3 and IL5RA with …
- 208000006673 Asthma 0 title abstract description 94
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sherrill et al. | Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis | |
| Jakobsdottir et al. | Susceptibility genes for age-related maculopathy on chromosome 10q26 | |
| Repapi et al. | Genome-wide association study identifies five loci associated with lung function | |
| Silverman et al. | Transforming growth factor-β1 promoter polymorphism C–509T is associated with asthma | |
| Donger et al. | New polymorphisms in the interleukin‐10 gene–relationships to myocardial infarction | |
| EP3218515B1 (en) | Therapeutic and diagnostic methods for il-33-mediated disorders | |
| Shu et al. | Impact of interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphism on IgA nephropathy | |
| Gao et al. | Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population | |
| Slager et al. | Genetics of asthma susceptibility and severity | |
| US11111539B2 (en) | Identification of pediatric onset inflammatory bowel disease loci and methods for use thereof for the diagnosis and treatment of the same | |
| Lan et al. | The association of interleukin-21 polymorphisms with interleukin-21 serum levels and risk of systemic lupus erythematosus | |
| Spector et al. | Association between a variation in LRCH1 and knee osteoarthritis: a genome‐wide single‐nucleotide polymorphism association study using DNA pooling | |
| Peng et al. | Association of transforming growth factor-β1 gene C-509T and T869C polymorphisms with atherosclerotic cerebral infarction in the Chinese: a case-control study | |
| Lee et al. | Genetic effect of CCR3 and IL5RA gene polymorphisms on eosinophilia in asthmatic patients | |
| JP2007507460A (en) | Use of genetic polymorphisms associated with therapeutic efficacy in inflammatory diseases | |
| Ramos et al. | The distal end of porcine chromosome 6p is involved in the regulation of skatole levels in boars | |
| ES2261239T3 (en) | DIAGNOSIS AND THERAPY FOR OSTEOPOROSIS. | |
| Nagpal et al. | TGFβ1 haplotypes and asthma in Indian populations | |
| Meyer et al. | Wading into the genomic pool to unravel acute lung injury genetics | |
| Vargas-Alarcon et al. | The− 974C> A (rs3087459) gene polymorphism in the endothelin gene (EDN1) is associated with risk of developing acute coronary syndrome in Mexican patients | |
| Raby et al. | Eotaxin polymorphisms and serum total IgE levels in children with asthma | |
| KR20060061350A (en) | Osteoporosis Diagnosis and Treatment | |
| Henriksson et al. | Four novel mutations in the ferrochelatase gene among erythropoietic protoporphyria patients | |
| Peng et al. | Association between polymorphisms in the signal transducer and activator of transcription and dilated cardiomyopathy in the Chinese Han population | |
| US11499194B2 (en) | CXR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same |